Literature DB >> 31130374

Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images.

A Danner1, E Brumpt2, M Alilet1, G Tio3, P Omoumi4, S Aubry5.   

Abstract

PURPOSE: The purpose of this study was twofold. First, to compare the contrast between spinal multiple myeloma (MM) focal lesions and surrounding bone marrow obtained on T2-weighted Dixon fat-only MR images to that obtained on T1-weighted spin-echo images. Second, to search for correlation between bone marrow fat fraction assessed by T2-weighted Dixon sequence and International Myeloma Working Group myeloma defining events.
MATERIALS AND METHODS: A total of 39 patients with 112 focal MM lesions were included. There were 25 men and 14 women with a mean age of 68.8±9.8 [SD] years (range: 49-88 years). Contrast between focal MM lesions and surrounding bone marrow was calculated on T1-weighted spin-echo and T2-weighted Dixon (including water-only and fat-only) images. Contrast between focal MM lesions and bone marrow was compared using ANOVA and post-hoc Tukey tests. Correlation between bone marrow fat fraction and myeloma defining events was assessed using Spearman's correlation test.
RESULTS: MM lesion contrast was greater on T2-weighted Dixon (F (2;93)=35.10) than on T1-weighted images (P<0.0001). Greatest MM lesion contrast was achieved with T2-weighted Dixon fat-only (0.63±0.21 [SD]; range: 0.06-0.91) compared to T2-weighted Dixon water-only (0.45±0.20 [SD]; range: 0.07-0.8) (P=0.0003) and T1-weighted (0.23±0.19 [SD]; range: 0.04-0.87) (P<0.0001) images. There were no significant correlations between myeloma defining events and fat fraction.
CONCLUSION: T2-weighted Dixon fat-only images provide greater contrast between MM lesions and adjacent bone marrow than T1-weighted images. The usefulness of a T1-weighted sequence associated to a T2-weighted Dixon sequence has to be determined.
Copyright © 2019 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bone marrow; Dixon sequence; Magnetic resonance imaging (MRI); Multiple myeloma

Mesh:

Year:  2019        PMID: 31130374     DOI: 10.1016/j.diii.2019.05.001

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  7 in total

1.  Current progress and future trends in imaging of musculoskeletal bone tumours.

Authors:  R Rajakulasingam; R Botchu
Journal:  J Clin Orthop Trauma       Date:  2021-10-07

2.  Comparison of lumbar degenerative disc disease using conventional fast spin echo T2W MRI and T2 fast spin echo dixon sequences.

Authors:  Asif Saifuddin; Ramanan Rajakulasingam; Rodney Santiago; Mateen Siddiqui; Michael Khoo; Ian Pressney
Journal:  Br J Radiol       Date:  2021-03-08       Impact factor: 3.039

3.  Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.

Authors:  Xiaodong Ji; Wenyang Huang; Huazheng Dong; Zhiwei Shen; Meizhu Zheng; Dehui Zou; Wen Shen; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-02

4.  MRI of non-specific low back pain and/or lumbar radiculopathy: do we need T1 when using a sagittal T2-weighted Dixon sequence?

Authors:  Fabio Zanchi; Raphaël Richard; Mahmoud Hussami; Arnaud Monier; Jean-François Knebel; Patrick Omoumi
Journal:  Eur Radiol       Date:  2020-02-04       Impact factor: 5.315

5.  The Dixon method in musculoskeletal MRI: from fat-sensitive to fat-specific imaging.

Authors:  Patrick Omoumi
Journal:  Skeletal Radiol       Date:  2021-12-20       Impact factor: 2.128

6.  Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.

Authors:  Mengtian Sun; Jingliang Cheng; Cuiping Ren; Yong Zhang; Yinhua Li; Ying Li; Suping Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-08

Review 7.  Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.

Authors:  Frederic E Lecouvet; Marie-Christiane Vekemans; Thomas Van Den Berghe; Koenraad Verstraete; Thomas Kirchgesner; Souad Acid; Jacques Malghem; Joris Wuts; Jens Hillengass; Vincent Vandecaveye; François Jamar; Olivier Gheysens; Bruno C Vande Berg
Journal:  Skeletal Radiol       Date:  2021-08-07       Impact factor: 2.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.